Day: May 25, 2022
SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public offering of 6,428,572 shares of its common stock at a price to the public of $14.00 per share. In addition, and in lieu of common stock, Chinook is offering to certain investors pre-funded warrants to purchase up to an aggregate of 1,071,428 shares of common stock at a purchase price of $13.9999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each such pre-funded warrant. The gross proceeds to Chinook from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Chinook, are expected to be $105 million. Chinook has granted the underwriters a 30-day...
Gran Tierra Energy Inc. Announces Exchange Offers of Certain Existing Notes for New Notes and the Solicitations of Consents to Proposed Amendments to the Existing Indentures
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, May 24, 2022 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) today announced the commencement of offers to Eligible Holders (as defined herein) to exchange (such offers, the “Exchange Offers”) (i) any and all of the outstanding 6.25% Senior Notes due 2025 issued by Gran Tierra Energy International Holdings Ltd. (“GTEIH”) on February 15, 2018 (CUSIP: 38502HAA3 / G4066TAA0; ISIN: US38502HAA32 / USG4066TAA00) (the “2025 Notes”), and (ii) any and all of the outstanding 7.750% Senior Notes due 2027 issued by the Company on May 23, 2019 (CUSIP: 38502JAA9 / U37016AA7; ISIN: US38502JAA97 / USU37016AA70) (the “2027 Notes” and, together with the 2025 Notes, the “Existing Notes”) for newly issued 8.750% Senior Secured Amortizing Notes due 2029 (the “New Notes”),...
Beam Global Schedules Fiscal First Quarter 2022 Financial Results Conference Call for May 25, 2022 at 4:30 p.m. ET
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), (the “Company”), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, announced that it will report its Fiscal First Quarter 2022 financial results on Tuesday May 24, 2022. Management will host a conference call on Wednesday May 25, 2022 at 4:30 p.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.
Conference call details:
Date: May 25, 2022Time: 4:30 p.m. Eastern/1:30 p.m. PacificToll-Free Dial-In Number: 1-844-739-3880International Dial-In Number: 1-412-317-5716
Pre-register for the call through this link: https://dpregister.com/sreg/10167545/f2f356d8cb
All...
Verrica Receives Complete Response Letter from the FDA for its NDA for VP-102 as a Direct Result of Deficiencies at General Reinspection of Sterling Pharmaceuticals Services, LLC
Written by Customer Service on . Posted in Public Companies.
Verrica has been advised that PAI (Pre-Approval Inspection) was conducted at Sterling and is not aware of any reported observations related to the PAI of VP-102 operations
Review Division had advised Verrica that the review of NDA was completed and label was ready to be communicated, except for Sterling’s classification status
Verrica has been notified that Sterling is on OAI (Official Action Indicated) status
WEST CHESTER, Pa., May 24, 2022 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum).
The...
Jamieson Wellness Inc. Announces Voting Results from 2022 Annual Meeting of Shareholders
Written by Customer Service on . Posted in Public Companies.
TORONTO, May 24, 2022 (GLOBE NEWSWIRE) — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 9, 2022 was elected as a director of the Company (a “Director”) at the annual meeting (the “Meeting”) of the holders of common shares of the Company (the “Common Shares”) held today. The number of Common Shares voted in person or by proxy for the election of each Director or withheld was as indicated below:Name of Nominee
Votes For
%
Votes Withheld
%Heather Allen
32,745,924
99.94%
18,860
0.06%Dr. Louis Aronne
32,746,066
99.94%
18,718
0.06%Tania Clarke
32,749,501
99.95%
15,283
0.05%Michael Pilato
32,745,960
99.94%
18,824
0.06%Timothy Penner
30,285,212
92.43%
2,479,572
7.57%Catherine...